CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its...
Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience
MarketBeat's weekly roundup covers a weaker June jobs report, tech sector rotation, and top analyst picks including TSLA, AVGO, PLTR, MRNA, and NEE heading into Q2 earnings season.
President Donald Trump’s stock transaction filings reveal multiple purchases of Moderna ($MRNA) during March 2026, followed by a partial sale on May 18. Since those trades, the FDA's Vaccines and Related...
Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines faces a multi-year path to revenue.
/Moderna%20Inc%20HQ-by%20hapabapa%20via%20iStock.jpg)
Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.
Provides broad overview of Company's research and early development programs expected to continue to fuel future growth